Cefotaxime Sodium

头孢噻肟钠

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameCefotaxime Sodium
Drug Alias Name头孢塞肟钠Cefotaximum西孢克拉瑞头孢泰克松头孢氨噻肟 +[12] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsEndometritis +[16] 
Global Approved IndicationsGram-Positive Bacterial InfectionsLyme DiseaseGram-Negative Bacterial Infections +[4] 
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryN/A
Original Approved Date1980/01/01
Country/TerritoryUnited StatesSwedenEgypt +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesU.S. Pharmaceuticals Holdings I
China Registration ClassN/A

Develop Information

Active CompaniesTanta UniversityUs Pharm HoldingsSichuan Long March Pharmaceutical Co Ltd
Inactive CompaniesGothenburg University
Active IndicationsPeritonitisGram-Positive Bacterial InfectionsLyme Disease +[5] 
Inactive IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsEndometritis +[11] 

Other Information

ATC CodeJ01DD01
Related LinksWikipediaDrugBankKEGG